Medical Diagnostics Joint Venture

The University of Birmingham and medical diagnostics specialists, Abingdon Health Ltd, have launched Bioscience Ventures Ltd (‘Bioscience Ventures’), a new joint initiative aimed at developing and marketing new diagnostics products for the healthcare and other industries.

Biosciences Ventures will focus on developing new diagnostic tools for conditions where there are currently unmet needs in the market such as various forms of cancer, genetic related diseases and platform technologies with applications in many areas of medicine including infectious disease testing, drug testing and veterinary applications utilising intellectual property developed at the

University of Birmingham.

Operating from the University’s campus in Edgbaston, and through its established trading subsidiary company, Alta Bioscience Ltd, Bioscience Ventures will also provide a variety of services such as analysis and synthesis of DNA, protein and other biochemicals to clients both on and off campus in the pharmaceutical and food industries.

The new joint venture will be led by Executive Chairman, Dr Chris Hand, who was former Chief Executive of medical diagnosticscompany, Cozart plc.